Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

From invisibility to readability: Recovering the ink of Herculaneum.

Parker CS, Parsons S, Bandy J, Chapman C, Coppens F, Seales WB.

PLoS One. 2019 May 8;14(5):e0215775. doi: 10.1371/journal.pone.0215775. eCollection 2019.

2.

Identifying lung cancer in patients with active pulmonary tuberculosis.

Parker CS, Siracuse CG, Litle VR.

J Thorac Dis. 2018 Oct;10(Suppl 28):S3392-S3397. doi: 10.21037/jtd.2018.07.11. Review.

3.

Misidentification of copperhead and cottonmouth snakes following snakebites.

Cox RD, Parker CS, Cox ECE, Marlin MB, Galli RL.

Clin Toxicol (Phila). 2018 Dec;56(12):1195-1199. doi: 10.1080/15563650.2018.1473583. Epub 2018 May 24.

PMID:
29792342
4.

Structural and effective connectivity in focal epilepsy.

Parker CS, Clayden JD, Cardoso MJ, Rodionov R, Duncan JS, Scott C, Diehl B, Ourselin S.

Neuroimage Clin. 2017 Dec 12;17:943-952. doi: 10.1016/j.nicl.2017.12.020. eCollection 2018.

5.

From damage to discovery via virtual unwrapping: Reading the scroll from En-Gedi.

Seales WB, Parker CS, Segal M, Tov E, Shor P, Porath Y.

Sci Adv. 2016 Sep 21;2(9):e1601247. eCollection 2016 Sep.

6.

Correction: Emergency Department Visits and Inpatient Admissions Associated with Priapism among Males with Sickle Cell Disease in the United States, 2006-2010.

Dupervil BM, Grosse SD, Burnett AL, Parker CS.

PLoS One. 2016 Aug 24;11(8):e0162056. doi: 10.1371/journal.pone.0162056. eCollection 2016.

7.

Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.

Yusuf HR, Hooper WC, Grosse SD, Parker CS, Boulet SL, Ortel TL.

Thromb Res. 2015 Jan;135(1):50-7. doi: 10.1016/j.thromres.2014.10.012. Epub 2014 Oct 22.

8.

Consensus between pipelines in structural brain networks.

Parker CS, Deligianni F, Cardoso MJ, Daga P, Modat M, Dayan M, Clark CA, Ourselin S, Clayden JD.

PLoS One. 2014 Oct 30;9(10):e111262. doi: 10.1371/journal.pone.0111262. eCollection 2014.

9.

Blood disorders and public health.

Richardson LC, Parker CS, Tsai J.

Am J Prev Med. 2014 Nov;47(5):656-7. doi: 10.1016/j.amepre.2014.07.006. Epub 2014 Sep 19. No abstract available.

10.

Meeting the emerging public health needs of persons with blood disorders.

Parker CS, Tsai J, Siddiqi AE, Atrash HK, Richardson LC.

Am J Prev Med. 2014 Nov;47(5):658-63. doi: 10.1016/j.amepre.2014.07.008. Epub 2014 Sep 19.

11.

Sickle cell disease--the American saga.

Siddiqi AE, Jordan LB, Parker CS.

Ethn Dis. 2013 Spring;23(2):245-8. No abstract available.

12.

Public health implications of sickle cell trait: a report of the CDC meeting.

Grant AM, Parker CS, Jordan LB, Hulihan MM, Creary MS, Lloyd-Puryear MA, Goldsmith JC, Atrash HK.

Am J Prev Med. 2011 Dec;41(6 Suppl 4):S435-9. doi: 10.1016/j.amepre.2011.09.012.

PMID:
22099370
13.

Sickle cell disease: the need for a public health agenda.

Yusuf HR, Lloyd-Puryear MA, Grant AM, Parker CS, Creary MS, Atrash HK.

Am J Prev Med. 2011 Dec;41(6 Suppl 4):S376-83. doi: 10.1016/j.amepre.2011.09.007.

PMID:
22099361
14.

Factors affecting the willingness of counselors to integrate preconception care into sexually transmitted disease clinics.

Parker CS, Ghaddar S, Zhang Q, Cooke B.

Womens Health Issues. 2010 Sep;20(5):329-34. doi: 10.1016/j.whi.2010.05.005.

PMID:
20800769
15.

Developing a public health research agenda for women with blood disorders.

Byams VR, Beckman MG, Grant AM, Parker CS.

J Womens Health (Larchmt). 2010 Jul;19(7):1231-4. doi: 10.1089/jwh.2010.2127.

PMID:
20575677
16.

Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007.

Yusuf HR, Atrash HK, Grosse SD, Parker CS, Grant AM.

Am J Prev Med. 2010 Apr;38(4 Suppl):S536-41. doi: 10.1016/j.amepre.2010.01.001.

17.

Burden of disease resulting from hemophilia in the U.S.

Siddiqi AE, Ebrahim SH, Soucie JM, Parker CS, Atrash HK.

Am J Prev Med. 2010 Apr;38(4 Suppl):S482-8. doi: 10.1016/j.amepre.2009.12.016.

PMID:
20331947
18.

Assessing emerging infectious threats to blood safety for the blood disorders community.

Trimble SR, Parker CS, Grant AM, Soucie JM, Reyes N.

Am J Prev Med. 2010 Apr;38(4 Suppl):S468-74. doi: 10.1016/j.amepre.2009.12.019.

PMID:
20331945
19.

The public health response to blood disorders.

Atrash HK, Parker CS.

Am J Prev Med. 2010 Apr;38(4 Suppl):S451-5. doi: 10.1016/j.amepre.2010.01.006.

PMID:
20331942
20.

Congenital erythropoietic porphyria in a longhorn calf.

Huxley JN, Lloyd EL, Parker CS, Woolf JR, Strugnell BW.

Vet Rec. 2009 Dec 5;165(23):694-5. No abstract available.

PMID:
19966335
21.

Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.

Platt AB, Localio AR, Brensinger CM, Cruess DG, Christie JD, Gross R, Parker CS, Price M, Metlay JP, Cohen A, Newcomb CW, Strom BL, Laskin MS, Kimmel SE.

Chest. 2010 Apr;137(4):883-9. doi: 10.1378/chest.09-0039. Epub 2009 Nov 10.

22.

Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics.

Cruess DG, Localio AR, Platt AB, Brensinger CM, Christie JD, Gross R, Parker CS, Price M, Metlay JP, Cohen A, Newcomb CW, Strom BL, Kimmel SE.

Int J Behav Med. 2010 Mar;17(1):33-42. doi: 10.1007/s12529-009-9052-6.

23.

Risk factors for nonadherence to warfarin: results from the IN-RANGE study.

Platt AB, Localio AR, Brensinger CM, Cruess DG, Christie JD, Gross R, Parker CS, Price M, Metlay JP, Cohen A, Newcomb CW, Strom BL, Laskin MS, Kimmel SE.

Pharmacoepidemiol Drug Saf. 2008 Sep;17(9):853-60. doi: 10.1002/pds.1556.

24.

Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study.

Parker CS, Chen Z, Price M, Gross R, Metlay JP, Christie JD, Brensinger CM, Newcomb CW, Samaha FF, Kimmel SE.

J Gen Intern Med. 2007 Sep;22(9):1254-9. Epub 2007 Jun 22.

25.

The influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study.

Kimmel SE, Chen Z, Price M, Parker CS, Metlay JP, Christie JD, Brensinger CM, Newcomb CW, Samaha FF, Gross R.

Arch Intern Med. 2007 Feb 12;167(3):229-35.

PMID:
17296877
26.

Improving women's health for the sake of our children.

Parker CS, Boulet SL, Atrash H.

J Womens Health (Larchmt). 2006 Jun;15(5):475-9.

PMID:
16796474
27.

Recommendations to improve preconception health and health care--United States. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care.

Johnson K, Posner SF, Biermann J, Cordero JF, Atrash HK, Parker CS, Boulet S, Curtis MG; CDC/ATSDR Preconception Care Work Group; Select Panel on Preconception Care.

MMWR Recomm Rep. 2006 Apr 21;55(RR-6):1-23.

28.
29.

Developmental regulation of the heat shock response by nuclear transport factor karyopherin-alpha3.

Fang X, Chen T, Tran K, Parker CS.

Development. 2001 Sep;128(17):3349-58.

30.

Site-specific inhibition of transcription factor binding to DNA by a metallointercalator.

Odom DT, Parker CS, Barton JK.

Biochemistry. 1999 Apr 20;38(16):5155-63.

PMID:
10213621
32.

Charting by exception.

Parker CS.

Caring. 1997 Mar;16(3):36-40, 42-4.

PMID:
10166265
33.

Allied health faculty attitudes toward rural clinical practice.

Boonyawiroj EB, Haven MC, Freeman VS, Parker CS, Muellenberg PA, Temme JB, Benschoter RA, Benson SJ.

J Allied Health. 1996 Summer;25(3):263-74.

PMID:
8884437
34.

Convergence of the optimized delta expansion for the connected vacuum amplitude: Anharmonic oscillator.

Arvanitis C, Jones HF, Parker CS.

Phys Rev D Part Fields. 1995 Sep 15;52(6):3704-3711. No abstract available.

PMID:
10019591
35.
36.

Extended variational approach to the SU(2) mass gap on the lattice.

Akeyo JO, Jones HF, Parker CS.

Phys Rev D Part Fields. 1995 Feb 1;51(3):1298-1304. No abstract available.

PMID:
10018587
37.
38.

Transcriptional activation mediated by the yeast AP-1 protein is required for normal cadmium tolerance.

Wemmie JA, Wu AL, Harshman KD, Parker CS, Moye-Rowley WS.

J Biol Chem. 1994 May 20;269(20):14690-7.

39.

BVA congress.

Craig TW, Parker CS.

Vet Rec. 1993 Oct 16;133(16):403-4. No abstract available.

PMID:
8310612
40.

dOct2, a Drosophila Oct transcription factor that functions in yeast.

Prakash K, Fang XD, Engelberg D, Behal A, Parker CS.

Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7080-4.

41.

The SV40 core sequence functions as a repressor element in yeast.

Zhang-Keck ZY, Kibbe WA, Moye-Rowley WS, Parker CS.

J Biol Chem. 1991 Nov 15;266(32):21362-7.

42.

Synthetic oligonucleotides recreate Drosophila fushi tarazu zebra-stripe expression.

Topol J, Dearolf CR, Prakash K, Parker CS.

Genes Dev. 1991 May;5(5):855-67.

43.

cDNA clone encoding Drosophila transcription factor TFIID.

Muhich ML, Iida CT, Horikoshi M, Roeder RG, Parker CS.

Proc Natl Acad Sci U S A. 1990 Dec;87(23):9148-52.

44.
45.

Transcriptional regulation of the Drosophila segmentation gene fushi tarazu (ftz)

Dearolf CR, Topol J, Parker CS.

Bioessays. 1990 Mar;12(3):109-13. Review. Erratum in: Bioessays 1990 Apr;12(4):198.

PMID:
2108665
46.
47.

Transcription factors.

Parker CS.

Curr Opin Cell Biol. 1989 Jun;1(3):512-8. Review. No abstract available.

PMID:
2576380
48.

Yeast YAP1 encodes a novel form of the jun family of transcriptional activator proteins.

Moye-Rowley WS, Harshman KD, Parker CS.

Genes Dev. 1989 Mar;3(3):283-92.

49.

Transcriptional control of Drosophila fushi tarazu zebra stripe expression.

Dearolf CR, Topol J, Parker CS.

Genes Dev. 1989 Mar;3(3):384-98.

50.

Isolation of the gene encoding the S. cerevisiae heat shock transcription factor.

Wiederrecht G, Seto D, Parker CS.

Cell. 1988 Sep 9;54(6):841-53.

PMID:
3044612

Supplemental Content

Loading ...
Support Center